Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Benzamide | HCID 2331 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| Reactant | HCID 68574436 | HCID 68574436 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 68577075 | HCID 68577075 | — |
Reaction Steps
(6-Bromo-quinolin-2-yl)-(5-methyl-furan-2-ylmethyl)-amine (prepared from 6-bromo-2-chloroquinoline and 5-methyl-2-furanmethanamine as described in example 43, step A, 200 mg, 0.631 mmol) was dissolved in 5 mL dioxane. Argon was bubbled through the solution for 2 minutes to remove oxygen. Benzamide (107 mg, 0.884 mmol), cesium carbonate (308 mg, 0.948 mmol) bis(dibenzylideneacetone)palladium (29 mg, 0.032 mmol) and 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (55 mg, 0.095 mmol) were added. The reaction mixture was stirred in a sealed tube at 100° C. for 16 h. The solvent was evaporated and the residue purified by flash chromatography on silica gel (heptane/ethyl acetate 100:0->60:40 gradient). The title compound was obtained as a white solid (110 mg, 49%), MS: m/e=358.3 (M+H+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08399674B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-72138ca8fb00495fad6dc46213e483ea |
|---|
| Source note | uspto-grants-2013_03 |
|---|